In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase

被引:26
|
作者
Wei, Wenjuan [1 ]
Yang, Haifei [1 ]
Liu, Yanyan [1 ,2 ,3 ]
Ye, Ying [1 ,2 ,3 ]
Li, Jiabin [1 ,2 ,3 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Jixi Rd 218, Hefei, Peoples R China
[2] Anhui Med Univ, Inst Bacterium Resistance, Hefei, Peoples R China
[3] Anhui Ctr Surveillance Bacterial Resistance, Hefei, Peoples R China
基金
美国国家科学基金会;
关键词
Antimicrobial resistance; Acinetobacter; Synergy; Susceptibility; Combination therapy; MOLECULAR EPIDEMIOLOGY; SULBACTAM; FOSFOMYCIN; TIGECYCLINE; IMIPENEM; RIFAMPIN; MULTICENTER; INFECTION; EFFICACY; PLUS;
D O I
10.1179/1973947815Y.0000000030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fifty extensively drug-resistant Acinetobacter baumannii (XDRAB) were isolated from patients. The chequerboard microdilution method was used to determine the in vitro activities of five colistin (COL)based combinations including COL+fosfomycin (FOS), COL+rifampicin (RIF), COL+imipenem (IMP), COL+sulbactam (SUP) and COL+levofloxacin (LVX). The synergistic activity was evaluated by the fractional inhibitory concentration index (FICI). According to our results, the combination of COL was synergistic with FOS, RIF, IMP, SUP and LVX with the ratios of 50, 72, 88, 92 and 64%, respectively. When combined with COL, the other five agents showed increased antimicrobial activities. In addition, two of the combinations, COL+RIF and COL+IMP, were more active than the combinations of COL+FOS, COL+SUP and COL+LVX. More importantly, these combination regimens could exert synergistic effects at the sub-minimum inhibitory concentration (MIC) levels against XDRAB strains.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [1] Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol
    Wei, Wen-juan
    Yang, Hai-fei
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 321 - 326
  • [2] Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China
    Li, Ying
    Guo, Qinglan
    Wang, Peng
    Zhu, Demei
    Ye, Xinyu
    Wu, Shi
    Wang, Minggui
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (01) : 101 - 108
  • [3] Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase, Nigeria
    Olaitan, Abiola Olumuyiwa
    Berrazeg, Meryem
    Fagade, Obasola Ezekiel
    Adelowo, Olawale Olufemi
    Alli, John Adeolu
    Rolain, Jean Marc
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (06) : E469 - E470
  • [4] An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China
    Zong, Zhiyong
    Lue, Xiaoju
    Valenzuela, Jubelle K.
    Partridge, Sally R.
    Iredell, Jon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (01) : 50 - 54
  • [5] In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
    Park, Gyun Cheol
    Choi, Ji Ae
    Jang, Sook Jin
    Jeong, Seok Hoon
    Kim, Choon-Mee
    Choi, In Sun
    Kang, Seong Ho
    Park, Geon
    Moon, Dae Soo
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (02) : 124 - 130
  • [6] In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii
    Cordoba, J.
    Coronado-Alvarez, N. M.
    Parra, D.
    Parra-Ruiz, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) : 7316 - 7319
  • [7] Outbreak of a multidrug resistant Acinetobacter baumannii producing OXA-23 carbapenemase on a neurological intensive care unit
    Fenner, I.
    Dyck, H.
    Wertheimer, D.
    Lensing, C.
    Kaase, M.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 94 - 94
  • [8] Carbapenem-Resistant Acinetobacter baumannii Producing OXA-23 in Thailand
    Niumsup, Pannika Ritvirool
    Boonkerd, Nitsara
    Tansawai, Uttapoln
    Tiloklurs, Mujarin
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2009, 62 (02) : 152 - 154
  • [9] GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey
    Zeka, Arzu Nazli
    Poirel, Laurent
    Sipahi, Oguz Resat
    Bonnin, Remy A.
    Arda, Bilgin
    Ozinel, Memetali
    Ulusoy, Sercan
    Bor, Canan
    Nordmann, Patrice
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) : 1145 - 1146
  • [10] IN VITRO ACTIVITY OF COLISTIN OR SULBACTAM IN COMBINATION WITH FOSFOMYCIN OR IMIPENEM AGAINST CLINICAL ISOLATES OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII PRODUCING OXA-23 CARBAPENEMASES
    Santimaleeworagun, Wichai
    Wongpoowarak, Payom
    Chayakul, Pantip
    Pattharachayakul, Sutthiporn
    Tansakul, Pimpimon
    Garey, Kevin W.
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (04) : 890 - 900